Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing
Contribuinte(s) |
K. J. Falke |
---|---|
Data(s) |
01/02/2001
|
Identificador | |
Idioma(s) |
eng |
Publicador |
Sringer-Verlag |
Palavras-Chave | #Critical Care Medicine #Antibiotics #Pseudomonas Infections #Pharmacokinetics #Cefpirome #Critically Ill #Beta-lactam Infusions #Intensive-care Patients #Organ Failure #Pseudomonas-aeruginosa #Intermittent Infusion #Protein-binding #Ceftazidime #Amikacin #Pharmacodynamics #Ciprofloxacin #Infections #C1 #320500 Pharmacology and Pharmaceutical Sciences #730100 Clinical (Organs, Diseases and Abnormal Conditions) #111502 Clinical Pharmacology and Therapeutics #110310 Intensive Care |
Tipo |
Journal Article |